U.S. Approves Pill Version Of Wegvy For Weight Loss

(AP) – U.S. regulators have approved a pill version of the weight-loss drug Wegovy. This gives Novo Nordisk an edge over Eli Lilly, whose similar drug is still under review. Both pills mimic a hormone that controls appetite. The Wegovy pill is expected to be available within weeks. Experts say oral pills could expand access and reduce costs for obesity treatments. In a clinical trial, participants taking Wegovy lost 13.6% of their body weight. The pills promise convenience, though Wegovy must be taken on an empty stomach.